
Department of Science, University of Basilicata, Potenza, Italy
Pharmaceutical development; Pharmaceutical chemistry; Medicinal and Pharmaceutical chemistry; Antioxidant activity; Synthetic organic chemistry; Heterocyclic chemistry; Medicinal chemistry; Organic synthesis; Cytotoxicity; Synthesis
Dr. Saturnino Carmela is a distinguished academic and researcher in the field of pharmaceutical sciences. She earned both her undergraduate degree in Pharmacy and her postgraduate degree in Pharmaceutical Chemistry from the University of Naples, where she later completed her Ph.D. in Pharmaceutical Sciences. Throughout her academic journey, Dr. Carmela was the recipient of numerous scholarships in recognition of her outstanding research contributions.
Currently, she serves as a Professor in the Department of Sciences and Medicinal Chemistry at the University of Basilicata. Her research interests lie in pharmaceutical chemistry and drug development, and she has published extensively in several high-impact, peer-reviewed journals.
Dr. Carmela is an active member of various international scientific societies and regularly participates in global conferences, contributing her insights and staying abreast of the latest developments in her field. Her dedication to advancing pharmaceutical research and education has made her a respected figure among her peers and a mentor to aspiring scientists.
Dear Colleagues,
Medicinal and Pharmaceutical Chemistry is a synthetic organic chemical and pharmacological process used to design and synthesize drugs, pharmaceuticals and personal care products. The main goal of this topical collection is to provide information on the state-of-art in the field of medicinal and pharmaceutical chemistry in different areas of drug discovery and development with a focus on original omics research.
In particular, it is focused on the rational design of new organic and inorganic drugs, but also on organic synthesis and reactivity, antioxidant activity, the synthesis of new multifunctional polymeric, and nanostructured materials, advanced methodologies, and pharmaceutical technology in the chemical and chemical-pharmaceutical fields. Additionally, novel synthetic approaches for creation multi-target-directed-ligands (MTDL), as well as monotarget strategy for drug discovery will be discussed. Contemporary approaches for improvement and focusing drug delivery on specific targets and bioavailability of drug-candidates will be provided and analyzed.
The results reported in this topical collection will further support medicinal chemistry research to exploit the pharmaceutical potential of new chemical entities, providing comprehensive insights and fostering innovation and collaboration within the research community.
Exploring Peganum harmala as a natural alternative to semaglutide: A novel approach to glucagon-like peptide-1 stimulation and insulin sensitization